Aetna
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Aetna's revenues will grow 8.5% and EPS will grow 3.0%.
The average estimate for revenue is $9.62 billion. On the bottom line, the average EPS estimate is $1.38.
Revenue details
Last quarter, Aetna reported revenue of $8.96 billion. GAAP reported sales were 16% higher than the prior-year quarter's $8.57 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, non-GAAP EPS came in at $0.94. GAAP EPS of $0.56 for Q4 were 45% lower than the prior-year quarter's $1.02 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 23.9%, 570 basis points worse than the prior-year quarter. Operating margin was 5.9%, 190 basis points worse than the prior-year quarter. Net margin was 1.9%, 240 basis points worse than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $40.80 billion. The average EPS estimate is $5.54.
Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 594 members out of 644 rating the stock outperform, and 50 members rating it underperform. Among 218 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 208 give Aetna a green thumbs-up, and 10 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Aetna is outperform, with an average price target of $52.94.
Is Aetna the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Aetna to My Watchlist.
